BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Sanofi’s Bad End-of-the-Year Continues With Axing of Its C. Diff Drug

  Sanofi terminated an experimental Clostridium difficile vaccine after an Independent Data Monitoring Committee concluded the Phase III trial was unlikely to hit its endpoints.

  December 4, 2017

   · 

  2 min read

   · 

  Alex Keown
• Business

  12 Sigma, a US-China Startup, Raises $30M for AI-Imaging

  12 Sigma Technologies, a San Diego medical imaging firm founded by a team of Chinese scientists, raised $30M in a B round led by China VC firm SBCVC.

  December 4, 2017

   · 

  1 min read
• 

  Business

  Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics

  The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics.

  December 4, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  CareFusion Issues Warning to Customers Over Alaris Syringe Pump Alarm

  The company warns that pumps made before 2008 may display an error message that could stop the pump from working.

  December 4, 2017

   · 

  1 min read
• Drug Development

  BioLineRx Reports Overall Survival Results From Long-Term Follow-Up of Phase IIa Trial in r/r AML

  The results demonstrate that the combination of BL-8040 with HiDAC in this difficult-to-treat patient population significantly improved overall survival, compared with historical data of HiDAC monotherapy.

  December 4, 2017

   · 

  6 min read
• Genetown

  ProMIS Neurosciences Announces Trading on OTCQB Venture Market

  ProMIS Neurosciences common shares will continue to trade on the Toronto Stock Exchange.

  December 4, 2017

   · 

  3 min read
• 

  Business

  What You Need to Know About Apostle

  Apostle, headquartered in Sunnyvale, Calif., hopes to file an IPO or establish other strong business collaborative routes in five years.

  December 4, 2017

   · 

  5 min read

   · 

  Mark Terry
• 

  Business

  What You Need to Know About BlueRock Therapeutics

  BlueRock Therapeutics, which has locations in Toronto, NYC and Cambridge, Mass., rocketed to existence in December 2016 with $225M in venture funding to focus on regenerative medicine, using iPSC therapies.

  December 4, 2017

   · 

  8 min read

   · 

  Mark Terry
• 

  Biotech Bay

  2 Bay Area Biotechs Expected to Grow 67% or Up Over the Next Five Years

  A look at two life science companies that are expected to grow more than 67 percent over the next five years.

  December 4, 2017

   · 

  2 min read

   · 

  Mark Terry
• GenomicCare (Shanghai) Completes Series A; Brings Total Funding to $25M

  Although GenomiCare did not disclose the size of the A round, the company did say it has raised $25M since its inception in 2015.

  December 4, 2017

   · 

  1 min read